National Bank of Canada’s ClearPoint Neuro CLPT Stock Holding History

National Bank of Canada’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$654	Hold	72	–	–	﹤0.01%	2716
2025 Q4	$982	Hold	72	–	–	﹤0.01%	2627
2025 Q3	$1.57K	Hold	72	–	–	﹤0.01%	2611
2025 Q2	$856	Hold	72	–	–	﹤0.01%	2721
2025 Q1	$854	Hold	72	–	–	﹤0.01%	2593
2024 Q4	$1.11K	Sell	72 -202	-74%	-$2.62K	﹤0.01%	2639
2024 Q3	$3.07K	Buy	+274	New	+$2.62K	﹤0.01%	2300
2022 Q1	–	Sell	-800	Closed	-$9K	–	2870
2021 Q4	$9K	Buy	+800	New	+$12K	﹤0.01%	2383

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

National Bank of Canada's CLPT Position: Q1 2026 in Review

National Bank of Canada held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 72 shares worth $654. The position accounts for ﹤0.01% of the portfolio, ranked #2716.

National Bank of Canada first reported a position in CLPT in Q4 2021 and has held it in 8 quarters since. The position peaked at $9K in Q4 2021. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

National Bank of Canada held 72 shares of ClearPoint Neuro worth $654 as of Q1 2026.
National Bank of Canada left its ClearPoint Neuro share count unchanged in Q1 2026.
ClearPoint Neuro made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2716 holding.
National Bank of Canada first reported a position in ClearPoint Neuro in Q4 2021 and has held it in 8 quarters since.
National Bank of Canada's ClearPoint Neuro position peaked at $9K in Q4 2021.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.